IKT Inhibikase Therapeutics, Inc.
Healthcare · Biological Products, (No Diagnostic Substances) · Market cap: $212.1M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $13.4K | $0 |
| 2022-Q3 | $4.0K | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $2.7M | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $3.0M | $0 |
| 2026-Q1 | $0 | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $0 |
| 2026-Q4 | $0 | $0 |
Bought$5.8M9 buy days
Sold$00 sell days
Net insider flow+$5.8Mnet buying · 5 years
Latest trade2025-11-21Sands Capital Alternatives, LLC
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2025-11-21 | Buy | Sands Capital Alternatives, LLC | 10% owner | 2,068,965 | $1.45 | $3.0M | 1 |
| 2024-10-21 | Buy | Bellini Roberto | Director | 1,460,000 | $1.37 | $2.0M | 1 |
| 2024-10-21 | Buy | Munshi Amit | Director | 365,000 | $1.37 | $500.1K | 1 |
| 2024-10-21 | Buy | Kush Arvind | Director | 145,000 | $1.37 | $198.7K | 1 |
| 2022-08-16 | Buy | Werner Milton H. | CEO | 5,000 | $0.80 | $4.0K | 1 |
| 2022-05-27 | Buy | Werner Milton H. | CEO | 5,000 | $0.98 | $4.9K | 1 |
| 2022-05-20 | Buy | Werner Milton H. | CEO | 10,000 | $0.60 | $6.0K | 1 |
| 2022-05-19 | Buy | FRATTAROLI JOSEPH | CFO | 3,948 | $0.64 | $2.5K | 1 |
| 2021-11-17 | Buy | Werner Milton H. | CEO | 23,589 | $1.97 | $46.6K | 5 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Sands Capital Alternatives, LLC | 10% owner | $3.0M | $0 | 2025-11-21 |
| Bellini Roberto | Director | $2.0M | $0 | 2024-10-21 |
| Munshi Amit | Director | $500.1K | $0 | 2024-10-21 |
| Kush Arvind | Director | $198.7K | $0 | 2024-10-21 |
| Werner Milton H. | CEO | $61.5K | $0 | 2022-08-16 |
| FRATTAROLI JOSEPH | CFO | $2.5K | $0 | 2022-05-19 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2024-10-21 | 3 | $2.7M | 42 | -19.1% (-10.8% raw) | +3.4% (+6.6% raw) | -2.5% (-13.1% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.